title: Occupational health issues in the pharmaceutical research and development process.
abstract: The research and development process for bringing a new drug to market can span 8-12 years and many testing stages, during which the number of people with the potential for occupational exposure to dangerous compounds and their targets (infectious organisms) increases. Drs. Klees and Joines carefully guide the reader through the R & D process, indicating potential hazards along the way.
authors.affiliation: BASF Corporation Mount Olive, New Jersey, USA.
authors.forename: J E
authors.initials: JE
authors.lastname: Klees
authors.forename: R
authors.initials: R
authors.lastname: Joines
mesh_terms: D000818:Animals; D001424:Bacterial Infections / Q000517:prevention & control*; D002986:Clinical Trials as Topic / Q000379:methods; D017277:Drug Approval; D004345:Drug Industry; D015386:Hazardous Substances / Q000009:adverse effects; D006801:Humans; D006967:Hypersensitivity / Q000209:etiology / Q000517:prevention & control*; D009784:Occupational Diseases / Q000517:prevention & control*; D016273:Occupational Exposure / Q000009:adverse effects*; D016272:Occupational Health; D010272:Parasitic Diseases / Q000517:prevention & control*; D012106:Research; D018570:Risk Assessment; D014481:United States; D014777:Virus Diseases / Q000517:prevention & control*
chemical_list: D015386:Hazardous Substances